Definium Therapeutics, Inc. (DFTX)
17.55
-0.21
(-1.18%)
USD |
NASDAQ |
Mar 05, 16:00
17.56
+0.01
(+0.06%)
After-Hours: 20:00
Definium Therapeutics Shareholders Equity (Quarterly) : 332.33M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | 80.66M |
| RxSight, Inc. | 275.68M |
| Plus Therapeutics, Inc. | 5.054M |
| Viridian Therapeutics, Inc. | 722.17M |
| Nutriband, Inc. | 7.549M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 440.10M |
| Total Liabilities (Quarterly) | 107.77M |
| Debt to Equity Ratio | 0.1221 |
| Current Ratio | 6.287 |
| Net Debt Paydown Yield | -0.25% |